R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

PURPOSE: The type 1 insulin-like growth factor 1 receptor (IGF-1R) has been implicated in the pathogenesis of the Ewing sarcoma family of tumors (ESFT). We conducted a multicenter phase II study of the fully human IGF-1R monoclonal antibody R1507 in patients with recurrent or refractory ESFT. PATIEN...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Pappo, Alberto S., Patel, Shreyaskumar R., Crowley, John, Reinke, Denise K., Kuenkele, Klaus-Peter, Chawla, Sant P., Toner, Guy C., Maki, Robert G., Meyers, Paul A., Chugh, Rashmi, Ganjoo, Kristen N., Schuetze, Scott M., Juergens, Heribert, Leahy, Michael G., Geoerger, Birgit, Benjamin, Robert S., Helman, Lee J., Baker, Laurence H.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society of Clinical Oncology 2011
الموضوعات:
Original Reports
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236654/
https://ncbi.nlm.nih.gov/pubmed/22025149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.34.0000
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة